Axogen Inc vs Dow Inc — how do they compare? Axogen Inc trades at $48.35 (market cap $2.61B), while Dow Inc trades at $31.07 (market cap $22.58B). The key difference: Dow Inc is far larger — about 8.7× Axogen Inc's market cap, and Dow Inc pays a 4.48% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | DOW | |
|---|---|---|
Market Cap | $2.61B | $22.58B |
Sector | Technology | Basic Materials |
52-Week High | $48.48 | $41.87 |
52-Week Low | $14.16 | $20.65 |
Enterprise Value | $2.52B | $38.27B |
Dividend Yield | — | 4.48% |
Signals from Pluang's Aura AI — not financial advice
AXGN is trading at $46.43, up 4.69% today, with strong technical momentum and bullish moving average signals. The company reported Q2 2026 revenue growth of 23.1% to $69.7 million and raised full-year guidance to at least $279 million. Despite recent earnings misses, analyst sentiment remains overwhelmingly positive with 84% buy ratings and a $54.33 price target.
The stock presents growth potential driven by expanding nerve care platform adoption and reimbursement improvements, but faces risks from persistent net losses (-$15.7M in 2025) and high valuation multiples (P/S 9.5). Near-term performance hinges on Q3 earnings delivery and continued commercial execution amid competitive pressures.
No Aura AI signal available yet.
Trailing returns across standard periods
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →